3.9 Article

Acetazolamide and bevacizumab combination therapy versus bevacizumab monotherapy in macular edema secondary to retinal vein occlusion

Related references

Note: Only part of the references are listed.
Article Ophthalmology

Sub-optimal gain in vision in retinal vein occlusion due to under-treatment in the real world: results from an open-label prospective study of Intravitreal Ranibizumab

Raja Narayanan et al.

Summary: The study showed that ranibizumab is well tolerated and effective in treating macular edema secondary to retinal vein occlusion in real-world clinical settings. However, there is under-treatment compared to controlled clinical trials, and the gain in vision is sub-optimal with under-treatment.

BMC OPHTHALMOLOGY (2021)

Article Ophthalmology

Vitrectomy for macular edema due to retinal vein occlusion

Kazuyuki Kumagai et al.

CLINICAL OPHTHALMOLOGY (2019)

Review Ophthalmology

RETINAL VEIN OCCLUSIONS, FROM BASICS TO THE LATEST TREATMENT

Mary Ho et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)

Article Ophthalmology

Intravitreal Anti-Vascular Endothelial Growth Factor Treatment and the Risk of Thromboembolism

Matthew B. Schlenker et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)

Review Ophthalmology

Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review

Taygan Yilmaz et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)

Article Ophthalmology

Results of bevacizumab as the primary treatment for retinal vein occlusions

M. S. Figueroa et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2010)

Article Ophthalmology

Natural History of Central Retinal Vein Occlusion: An Evidence-Based Systematic Review

Rachel L. McIntosh et al.

OPHTHALMOLOGY (2010)

Article Ophthalmology

BEVACIZUMAB COMPARED WITH MACULAR LASER GRID PHOTOCOAGULATION FOR CYSTOID MACULAR EDEMA IN BRANCH RETINAL VEIN OCCLUSION

Vincenzo Russo et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)